Stocks Hitting 52-Week Lows

by Lisa Levin, Benzinga Editor

June 28, 2016 11:01 AM | 1 min read | Make a Comment

Regulus Therapeutics Inc RGLS shares fell 49.20 percent to touch a new 52-week low of $2.55 after the FDA said it had placed the company’s lead product candidate, RG-101 for the treatment of hepatitis C virus (HCV) infection, on clinical hold.
Celyad SA (ADR) CYAD shares touched a new 52-week low of $27.293. Celyad reported that its CHART-1 Phase 3 trial did not meet primary endpoint.
Babcock & Wilcox Enterprises Inc BW shares fell 22.28 percent to reach a new 52-week low of $14.72 after the company lowered its 2016 earnings forecast and announced plans to cut over 200 positions in North America immediately.
MagneGas Corporation MNGA shares fell 10.59 percent to touch a new 52-week low of $0.617. On Monday, MagneGas reported a $10.6 million private placement.

Posted In: News Movers & Shakers Intraday Update Markets 52 Week Lows 52-Week Lows

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.